Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
8
×
celgene
8
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
8
×
wisconsin top stories
biotech
pfizer
fda
genentech
johnson & johnson
abbvie
acquisition
clinical trials
eli lilly
immunotherapy
m&a
merck
What
bio
roundup
drug
news
annual
approved
biogen
celgene
conference
days
disease
fda
liver
medical
nash
race
week
adu
aducanumab
advanced
airport
alnylam’s
alzheimer’s
amyloid
angst
apocalypse
approval
august
bagged
beats
beds
bff
bids
billions
biogen’s
biopharma
biotech
brammer
breast
busy
Language
unset
Current search:
" bristol-myers squibb "
×
celgene
×
" wisconsin blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front